Cadmium induces apoptotic program imbalance and cell cycle inhibitor expression in cultured human astrocytes

Area of Science:

• Neuroscience
• Toxicology
• Cell Biology

Background:

• Cadmium is a neurotoxic heavy metal known to impair neurogenesis and induce neurodegenerative diseases.
• While cadmium's effects on various cell types are documented, its impact on astrocyte proteins regulating oxidative stress, apoptosis, and proliferation remains less understood.

Purpose of the Study:

• To investigate the effects of cadmium on antioxidant enzymes, apoptosis regulators, and cell cycle inhibitors in astrocytes.
• To elucidate the mechanisms underlying cadmium-induced astrocyte apoptosis and cell cycle arrest.

Main Methods:

• Astrocytes were exposed to varying concentrations of cadmium (≥20 μM).
• Analysis included assessment of DNA fragmentation, mRNA expression of antioxidant enzymes (catalase, glutathione S transferase-A4), protein levels of Bcl-2 and Bax, and cell cycle phase distribution.
• Expression of p53, p21, and p27 proteins was evaluated.

Main Results:

• Cadmium exposure induced astrocyte apoptosis, evidenced by DNA fragmentation.
• Reduced mRNA expression of catalase and glutathione S transferase-A4, alongside altered Bcl-2/Bax ratios (downregulation of Bcl-2, upregulation of Bax), was observed.
• Cadmium suppressed astrocyte proliferation, causing S and G2/M phase cell cycle arrest and increased p53, p21, and p27 expression.

Conclusions:

• Cadmium alters critical proteins involved in oxidative stress and apoptosis pathways in astrocytes.
• Cadmium-induced cytotoxicity in astrocytes involves apoptosis and cell cycle arrest, mediated by specific molecular changes.
• Findings highlight potential therapeutic targets for mitigating cadmium-induced neurotoxicity.